These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2151441

  • 21. Novel mechanism of resistance to glycopeptide antibiotics in Enterococcus faecium.
    Cremniter J, Mainardi JL, Josseaume N, Quincampoix JC, Dubost L, Hugonnet JE, Marie A, Gutmann L, Rice LB, Arthur M.
    J Biol Chem; 2006 Oct 27; 281(43):32254-62. PubMed ID: 16943188
    [Abstract] [Full Text] [Related]

  • 22. The site of inhibition of bacterial cell wall peptidoglycan synthesis by azureomycin B, a new antibiotic.
    Spiri-Nakagawa P, Oiwa R, Tanaka Y, Tanaka H, Omura S.
    J Biochem; 1980 Aug 27; 88(2):565-70. PubMed ID: 6774972
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum.
    Ferain T, Hobbs JN, Richardson J, Bernard N, Garmyn D, Hols P, Allen NE, Delcour J.
    J Bacteriol; 1996 Sep 27; 178(18):5431-7. PubMed ID: 8808932
    [Abstract] [Full Text] [Related]

  • 25. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
    Allen NE, LeTourneau DL, Hobbs JN.
    Antimicrob Agents Chemother; 1997 Jan 27; 41(1):66-71. PubMed ID: 8980756
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry.
    Chang JD, Foster EE, Thadani AN, Ramirez AJ, Kim SJ.
    J Bacteriol; 2017 Aug 01; 199(15):. PubMed ID: 28507244
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1988 Aug 01; 14(10):617-9. PubMed ID: 2977587
    [Abstract] [Full Text] [Related]

  • 29. Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.
    Boger DL.
    Med Res Rev; 2001 Sep 01; 21(5):356-81. PubMed ID: 11579438
    [Abstract] [Full Text] [Related]

  • 30. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.
    Messer J, Reynolds PE.
    FEMS Microbiol Lett; 1992 Jul 01; 73(1-2):195-200. PubMed ID: 1521770
    [Abstract] [Full Text] [Related]

  • 31. Activation of the L,D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D,D-carboxypeptidase in Enterococcus faecium.
    Sacco E, Hugonnet JE, Josseaume N, Cremniter J, Dubost L, Marie A, Patin D, Blanot D, Rice LB, Mainardi JL, Arthur M.
    Mol Microbiol; 2010 Feb 01; 75(4):874-85. PubMed ID: 20025663
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II.
    Hu Y, Helm JS, Chen L, Ye XY, Walker S.
    J Am Chem Soc; 2003 Jul 23; 125(29):8736-7. PubMed ID: 12862463
    [Abstract] [Full Text] [Related]

  • 35. Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.
    Somma S, Gastaldo L, Corti A.
    Antimicrob Agents Chemother; 1984 Dec 23; 26(6):917-23. PubMed ID: 6240963
    [Abstract] [Full Text] [Related]

  • 36. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C, Chen L, Barrett D, Panzone G, Sun B, Falcone B, Oberthür M, Donadio S, Walker S, Kahne D.
    J Am Chem Soc; 2005 Mar 16; 127(10):3250-1. PubMed ID: 15755121
    [Abstract] [Full Text] [Related]

  • 37. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding.
    Goldman RC, Baizman ER, Longley CB, Branstrom AA.
    FEMS Microbiol Lett; 2000 Feb 15; 183(2):209-14. PubMed ID: 10675585
    [Abstract] [Full Text] [Related]

  • 38. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D.
    Science; 1999 Apr 16; 284(5413):507-11. PubMed ID: 10205063
    [Abstract] [Full Text] [Related]

  • 39. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.
    Münch D, Engels I, Müller A, Reder-Christ K, Falkenstein-Paul H, Bierbaum G, Grein F, Bendas G, Sahl HG, Schneider T.
    Antimicrob Agents Chemother; 2015 Feb 16; 59(2):772-81. PubMed ID: 25403671
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.